Correlation Between Molecular Genetic Analysis and Nuclear Pleomorphism in Long-Term Recurrent and Metastatic Chordoma
Authors:
- Sarah Rebecca UllmannSUSarah Rebecca Ullmann
- Julian SchreierJSJulian Schreier
- Joana Maria UllmannJUJoana Maria Ullmann
- Marilena GeorgiadesMGMarilena Georgiades
- Christoph Hubertus LohmannCLChristoph Hubertus Lohmann
- Martin RöpkeMRMartin Röpke
- Denny SchanzeDSDenny Schanze
- Juan Carlos Alberto Uribe CaputiJCJuan Carlos Alberto Uribe Caputi
- Sabine FrankeSFSabine Franke
- Franziska Sabrina KarrasFKFranziska Sabrina Karras
- Albert RoessnerARAlbert Roessner
Preprint
- 3 February 2026
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Background/Objectives: Recurrences and metastases occur frequently in chordoma and are the main influence on overall survival. However, prognostic biomarkers for recurrence remain limited. This study examines whether quantitative nuclear morphometry captures recurrence evolution and whether it aligns with immunophenotype and genomic profiling. Methods: 26 specimens from 12 adults (eight non-recurrent tumors and four patients with multiple long-term recurrences and metastases over seven to sixteen years) were analyzed using whole-exome-sequencing, immunohistochemistry and nuclear morphometry. Results: Imaging studies and routine histology showed no consistent differences between groups. Morphometry revealed substantial intertumoral variability among non-recurrent tumors and significant longitudinal nuclear remodeling throughout recurrences, dominated by increased nuclear size and asymmetry as well as altered shape. Primary tumors from patients who later recurred had smaller, more asymmetric and denser nuclei than non-recurrent tumors. Recurrent samples showed higher proliferation and decreased lamin A/C expression with focal disruption and detachment from the nuclear envelope in pleomorphic nuclei. The tumor mutational burden was overall low, varied between patients and timepoints and tended to be higher in recurrent cases. Conclusions: Quantitative nuclear morphometry, integrated with immunophenotyping and genomic profiling captures recurrence-associated phenotypic remodeling in chordoma and may support/train future AI-models for risk stratification.Keywords
All Related Versions
- Version 1, 2026-02-03, Preprints
- Published version: Cancers, 18 (6), 898.
This publication has 83 references indexed in Scilit:
- At the nucleus of cancer: how the nuclear envelope controls tumor progressionMedcomm, 2025
- Single-cell transcriptome profiling reveals intra-tumoral heterogeneity in human chordomasCancer Immunology, Immunotherapy, 2022
- Histopathological characteristics and artificial intelligence for predicting tumor mutational burden-high colorectal cancerJournal of Gastroenterology, 2021
- Chordome: Gibt es eine molekulargenetische Grundlage für Diagnostik und Therapie?Der Pathologe, 2020
- Tumor mutation burden and recurrent tumors in hereditary lung cancerCancer Medicine, 2019
- Expression of Lamin A/C in early-stage breast cancer and its prognostic valueBreast Cancer Research and Treatment, 2019
- Notochordale TumorenDer Pathologe, 2017
- Loss of SMARCB1/INI1 expression in poorly differentiated chordomasActa Neuropathologica, 2010
- Cancer nucleus: Morphology and beyondDiagnostic Cytopathology, 2010
- Skull base and nonskull base chordomasCancer, 2003